Pharmaceuticals & Therapeutics

A new report shows California's self-insured employers face a puzzling trend: workers' comp claims are at a 5-year low, yet costs are surging. Why?

Intended to heal, some Physician Health Programs are accused of using flawed science and financial coercion to ruin careers. Are they a safety net or a trap?

Alani Skin MD's "Best Med Spa" award reveals more than local popularity; it's a masterclass in leveraging market trends and customer loyalty.

A two-year delay for Carbios' biorecycling plant in China isn't a failure, but a harsh lesson in scaling innovation. Here's what it means for the future.

A top national law firm opens in Fort Worth, but the real story is its leader—a hometown hero. This is how institutional innovation meets deep community roots.

NexTel Medical acquires two telehealth firms for an instant $135K in monthly revenue, aiming to launch its Maxasome™ exosome therapies to 1,850 clinics.

As its CEO heads to a top investor conference, Zealand Pharma leverages AI and novel peptides to challenge giants in the multi-billion-dollar obesity market.

A small startup just raised $4M to solve the biggest problem in tech: making AR glasses affordable. Their secret isn't a new gadget, but a materials science breakthrough.

A new study reveals an 'early warning system' in infant guts, offering a window to combat the atopic march before allergies take hold. Is this the future?

As psychedelics go mainstream, a new initiative asks a hard question: what about those most harmed by their prohibition? MAPS' latest project is a radical rethink.

Cell therapies promise miracles, but a decades-old test for cell health is flawed. A new global standard aims to bring much-needed precision and safety.

Montara Therapeutics' new MJFF grant isn't just about Parkinson's. It's a bet on a 'BrainOnly' platform that could unlock a new era for CNS therapies.

A generational shift is underway as Millennials and Gen Z flock to the pre-owned luxury watch market, armed with data and viewing timepieces as tangible investments.

With a fresh $31M, Advanced NanoTherapies is advancing a first-of-its-kind dual-drug nanoparticle balloon, a technology poised to disrupt the market.

A new partnership between Volpi Foods and Blaze Pizza signals a major shift, as ethical sourcing and artisanal quality become key drivers in fast-casual dining.

Quoin Pharmaceuticals files the first-ever drug application for Peeling Skin Syndrome, offering a glimmer of hope for patients with no treatment options.

As one major allergy drug exits, a biotech startup is testing a new path: a microneedle skin stamp. Is this the future of allergy treatment?

A German-Japanese partnership is rewriting the rules of battery development, using a novel electrolyte and a clever licensing strategy to unleash unprecedented power.

A novel probiotic, sourced from an elite athlete's gut, has navigated the FDA's complex regulatory maze, signaling a major shift for the entire industry.

Upcoming study results for Bayer's KERENDIA could unlock a new treatment for millions with non-diabetic chronic kidney disease, a vast and underserved group.